Consensus NLP Quietly Filed Form D For $29.7M. DJ Patil And Jared Hecht Are Both On The Board.

Today’s RIP: When the former US Chief Data Scientist joins a private company’s board, it’s a signal. DJ Patil’s SEC insider footprint is empty — he rarely takes board seats. His appearance on Consensus NLP’s Form D, alongside Jared Hecht and a medical-device veteran, is the most interesting cap table to file this week. Total LinkedIn coverage so far: zero.

THE DEAL

Consensus NLP Inc. filed SEC Form D on June 24, 2026, declaring a $29.7M offering with $29.7M sold to date. Boston, MA. Industry: Other Technology. Year of incorporation: 2021. Entity type: Corporation.

The round closed fully on filing day. No press release. No LinkedIn announcement from the founder. A search for “Consensus NLP” on LinkedIn in the last 30 days returns no results at all. This is a company that wanted the legal disclosure done and the public conversation deferred.

THE CAP TABLE

Four related persons. Three directors and one CEO, with two of the three director seats held by people who don’t normally show up on private-company filings.

Name	Role	SEC Insider Footprint
Christian Salem	Executive Officer, Director	None. CEO of Consensus NLP.
Eric Olson	Director	8 filings. Issuers include AMEDICA Corp (medical device, public).
Jared Hecht	Director	None on insider forms. Founder of Fundera (sold to NerdWallet) and GroupMe (sold to Skype).
DJ Patil	Director	None on insider forms. Former US Chief Data Scientist under President Obama.

The Hecht and Patil seats are both unusual. Hecht is a serial founder who almost never sits on outside boards — his time has gone to building his own companies. Patil has historically been an advisor, not a director. For both of them to take Director (not Advisor) roles on the same private company means they consider Consensus NLP serious work, not portfolio babysitting.

Eric Olson’s SEC footprint is the operational counterweight. Eight filings across medical-device issuers including AMEDICA tells you he understands FDA-regulated revenue, multi-year sales cycles, and the discipline that selling into healthcare requires.

THE PATTERN

This cap table is built for one specific thesis: NLP for high-stakes regulated industries.

DJ Patil’s career arc — LinkedIn data science, US CDS under Obama, RelationalAI — has consistently centered on the question of whether AI can be trusted with decisions that have legal, medical, or civic consequences. He doesn’t typically join consumer or developer-tool boards. His presence on Consensus NLP says the company is building NLP that needs to be defensible in a courtroom, a clinic, or a regulatory filing.

Jared Hecht’s contribution is different. Fundera was a SMB lending marketplace — high-friction, regulated, B2B sales motion against incumbents. Hecht knows how to build distribution into industries where the buyer is conservative and the regulator is watching. That’s a specific kind of company-building muscle.

Eric Olson’s AMEDICA history adds medical-device commercial discipline. AMEDICA went public and had to navigate the path from lab to FDA to commercial revenue. If Consensus NLP is targeting healthcare NLP — clinical documentation, payer-provider communication, regulatory filings — Olson is the right cap-table member to have.

Read the three together and the company shape comes into focus. Consensus NLP is building natural-language processing for industries where the output has to be auditable, defensible, and regulatory-ready. Boston headquarters is consistent with a healthcare or life-sciences focus given the local talent pool (Mass General, BIDMC, Broad Institute, Harvard Medical).

The fully-sold $29.7M with no press release suggests the round was placed quietly with strategic and institutional money, not auction-style with VC competition. That pattern usually means the syndicate was assembled before the founder went out — the kind of round that happens when DJ Patil makes one phone call.

WHAT WE’LL WATCH

When	What to look for
Day 30	First Christian Salem LinkedIn post about the round, or continued silence. Continued silence suggests true stealth through product launch.
Day 45	Hiring spike. Watch for ML research / regulated-industry product / clinical informatics roles. The hire mix will confirm the regulated-industry thesis.
Day 60	First customer pilot announcement. Healthcare and finance customers anonymize early-stage relationships, so expect a press release rather than a LinkedIn post.
Day 90	DJ Patil writes or speaks publicly about regulated NLP. His public commentary follows his board positions by a quarter.

POPS & DROPS

• The signal: $29.7M Form D, fully sold, fully silent.
• The cap table: Patil + Hecht + Olson + Salem. Two directors who almost never take seats, plus a medical-device operator.
• The Boston location: Consistent with healthcare / clinical informatics focus.
• The thesis read: NLP for high-stakes regulated industries where output must be defensible. Healthcare or finance, most likely healthcare.
• The story to watch: First customer pilot. The category becomes obvious the moment the first logo lands.

---

Source: SEC EDGAR Form D filing dated 2026-06-24, CIK 0001894862. SEC insider filing counts via EDGAR full-text search across forms 3, 4, and 5. LinkedIn search for “Consensus NLP” past 30 days returned no results as of this writing.

Saw a B2B SaaS company close a round? Send it on LinkedIn.